Lower serotonin transporter binding in patients with cervical dystonia is associated with psychiatric symptoms
- PMID: 29071431
- PMCID: PMC5656503
- DOI: 10.1186/s13550-017-0338-4
Lower serotonin transporter binding in patients with cervical dystonia is associated with psychiatric symptoms
Abstract
Background: Cervical dystonia (CD) is often accompanied by depressive symptoms, anxiety, and jerks/tremor. The dopamine transporter (DAT) binding is related with both depressive symptoms and jerks/tremor in CD. Serotonergic and dopaminergic systems are closely related. As serotonin is involved in the pathophysiology of psychiatric symptoms and jerks, we expected an altered serotoninergic system in CD. We hypothesized that CD is associated with reduced serotonin transporter (SERT) binding, more specific that SERT binding is lower in CD patients with psychiatric symptoms and/or jerks/tremor compared to those without, and to controls. The balance between SERT and DAT binding can be altered in different CD phenotypes.
Results: In 23 CD patients and 14 healthy controls, SERT binding in the diencephalon/midbrain was assessed using [123I]FP-CIT SPECT, with a brain-dedicated system. The specific to non-specific binding ratio (binding potential; BPND) to SERT was the main outcome measure. There was a clear trend towards reduced SERT BPND in CD patients with psychiatric symptoms compared to those without (p = 0.05). There was no correlation between SERT binding and dystonia, jerks, or anxiety. There was a significant positive correlation between extrastriatal SERT and striatal DAT BPND in CD patients with jerks, but not in patients without jerks.
Conclusion: CD patients with psychiatric symptoms have lower SERT binding in the midbrain/diencephalon, while dystonia and jerks appear unrelated to SERT binding. The balance between extrastriatal SERT and striatal DAT binding is different in CD with and without jerks.
Keywords: Cervical dystonia; Depression; SPECT; Serotonin transporter (SERT).
Conflict of interest statement
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
Similar articles
-
The Effect of Escitalopram on Central Serotonergic and Dopaminergic Systems in Patients with Cervical Dystonia, and Its Relationship with Clinical Treatment Effects: A Double-Blind Placebo-Controlled Trial.Biomolecules. 2020 Jun 8;10(6):880. doi: 10.3390/biom10060880. Biomolecules. 2020. PMID: 32521736 Free PMC article. Clinical Trial.
-
The relationship between the dopaminergic system and depressive symptoms in cervical dystonia.Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1375-1382. doi: 10.1007/s00259-017-3664-x. Epub 2017 Mar 17. Eur J Nucl Med Mol Imaging. 2017. PMID: 28314910 Free PMC article.
-
Relationships between Serotonin Transporter Binding in the Raphe Nuclei, Basal Ganglia, and Hippocampus with Clinical Symptoms in Cervical Dystonia: A [11C]DASB Positron Emission Tomography Study.Front Neurol. 2018 Feb 28;9:88. doi: 10.3389/fneur.2018.00088. eCollection 2018. Front Neurol. 2018. PMID: 29541052 Free PMC article.
-
Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An 123I-FP-CIT SPECT study.Neuroimage Clin. 2019;22:101755. doi: 10.1016/j.nicl.2019.101755. Epub 2019 Mar 12. Neuroimage Clin. 2019. PMID: 30884365 Free PMC article.
-
Evaluation of the superselective radioligand [123I]PE2I for imaging of the dopamine transporter in SPECT.Dan Med Bull. 2011 May;58(5):B4279. Dan Med Bull. 2011. PMID: 21535991 Review.
Cited by
-
Non-Motor Manifestations in Idiopathic Dystonia with Focal Onset - A Pilot Study.J Med Life. 2020 Apr-Jun;13(2):170-174. doi: 10.25122/jml-2020-0094. J Med Life. 2020. PMID: 32742509 Free PMC article.
-
The use of sertraline to treat an adolescent of dystonia comorbid with major depressive disorder with psychotic features.Neuropsychopharmacol Rep. 2024 Mar;44(1):275-279. doi: 10.1002/npr2.12401. Epub 2023 Nov 20. Neuropsychopharmacol Rep. 2024. PMID: 37987035 Free PMC article.
-
Cognitive and Neuropsychiatric Impairment in Dystonia.Curr Neurol Neurosci Rep. 2022 Nov;22(11):699-708. doi: 10.1007/s11910-022-01233-3. Epub 2022 Oct 6. Curr Neurol Neurosci Rep. 2022. PMID: 36201146 Free PMC article. Review.
-
Development of a New Care Pathway for Depression and Anxiety in Adult-Onset Isolated Dystonia.Mov Disord Clin Pract. 2023 Jan 30;10(3):415-426. doi: 10.1002/mdc3.13655. eCollection 2023 Mar. Mov Disord Clin Pract. 2023. PMID: 36949792 Free PMC article.
-
The Effect of Escitalopram on Central Serotonergic and Dopaminergic Systems in Patients with Cervical Dystonia, and Its Relationship with Clinical Treatment Effects: A Double-Blind Placebo-Controlled Trial.Biomolecules. 2020 Jun 8;10(6):880. doi: 10.3390/biom10060880. Biomolecules. 2020. PMID: 32521736 Free PMC article. Clinical Trial.
References
-
- Perlmutter JS, Mink JW. Dysfunction of dopaminergic pathways in dystonia. Adv Neurol. 2004;94:163–170. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials